{
  "id": 14690277,
  "title": "Nvidia-backed AI drug developer Iambic is raising $150 million in U.S. IPO",
  "url": "https://urgent.news/2026/10/15/nvidia-backed-ai-drug-developer-iambic-is-raising-150-million-in-u-s",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-15T12:00:27.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/iambic-therapeutics-ipo-nvidia-ai-drug-101526"
  },
  "original_language": "en",
  "account": null,
  "summary": "The San Diego company's stock is expected to begin trading on Nasdaq Thursday under the ticker IAM, with the offering expected to close Friday",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "BioPharma Dive",
        "title": "Iambic, an AI drug discovery specialist, banks $150M in an IPO",
        "url": "https://urgent.news/2026/10/15/iambic-an-ai-drug-discovery-specialist-banks-150m-in-an-ipo",
        "published": "2026-10-15T00:08:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}